CCM
NVO

Carderock Capital Management’s Novo Nordisk NVO Stock Holding History

Carderock Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,500
Closed -$120K – 126
2021
Q3 		$120K Buy
+2,500
New +$121K 0.03% 87
2019
Q2 		– Sell
-11,002
Closed -$288K – 74
2019
Q1 		$288K Hold
11,002
– – 0.12% 69
2018
Q4 		$253K Sell
11,002
-2
-0% -$44 0.13% 66
2018
Q3 		$259K Sell
11,004
-2
-0% -$49 0.1% 75
2018
Q2 		$254K Hold
11,006
– – 0.11% 75
2018
Q1 		$271K Sell
11,006
-150
-1% -$3.94K 0.12% 75
2017
Q4 		$299K Hold
11,156
– – 0.13% 73
2017
Q3 		$269K Sell
11,156
-650
-6% -$14.7K 0.12% 72
2017
Q2 		$253K Sell
11,806
-2,216
-16% -$44.7K 0.11% 75
2017
Q1 		$240K Sell
14,022
-834
-6% -$14.5K 0.11% 74
2016
Q4 		$266K Sell
14,856
-123,152
-89% -$2.23M 0.13% 73
2016
Q3 		$2.87M Sell
138,008
-87,962
-39% -$2.18M 1.44% 34
2016
Q2 		$6.08M Sell
225,970
-18,650
-8% -$511K 3.22% 1
2016
Q1 		$6.63M Sell
244,620
-4,202
-2% -$113K 3.4% 2
2015
Q4 		$7.23M Buy
248,822
+472
+0.2% +$13.1K 3.76% 1
2015
Q3 		$6.74M Buy
248,350
+1,682
+0.7% +$47.6K 3.76% 3
2015
Q2 		$6.75M Buy
246,668
+288
+0.1% +$8.1K 3.39% 3
2015
Q1 		$6.58M Sell
246,380
-32,936
-12% -$758K 3.19% 3
2014
Q4 		$5.91M Sell
279,316
-6,918
-2% -$155K 2.91% 3
2014
Q3 		$6.82M Sell
286,234
-5,902
-2% -$136K 3.5% 3
2014
Q2 		$6.75M Sell
292,136
-2,300
-0.8% -$50.8K 3.52% 1
2014
Q1 		$6.72M Sell
294,436
-2,484
-0.8% -$52.9K 3.42% 1
2013
Q4 		$5.49M Buy
296,920
+30,330
+11% +$529K 2.88% 5
2013
Q3 		$4.51M Buy
266,590
+3,830
+1% +$64.4K 2.62% 9
2013
Q2 		$4.07M Buy
+262,760
New +$4.37M 2.41% 11

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Carderock Capital Management's NVO Position: Q4 2021 in Review

Carderock Capital Management sold out of Novo Nordisk (NVO) in Q4 2021, closing a stake of 2,500 shares — an estimated $120K sold.

Carderock Capital Management first reported a position in NVO in Q2 2013 and held it in 25 quarters. The position peaked at $7.23M in Q4 2015. 887 funds tracked by Wall St. Rank hold NVO as of Q4 2021.

  • Carderock Capital Management reported no remaining Novo Nordisk position as of Q4 2021 after selling out during the quarter.
  • Carderock Capital Management sold 2,500 Novo Nordisk shares in Q4 2021, an estimated $120K.
  • Carderock Capital Management first reported a position in Novo Nordisk in Q2 2013 and held it in 25 quarters.
  • Carderock Capital Management's Novo Nordisk position peaked at $7.23M in Q4 2015.
  • 887 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2021.

Based on Carderock Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.